Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. - Wikidata - awgldk - TriplyDB

Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

http://www.wikidata.org/entity/Q30698121

about

Oncolytic adenovirus-mediated therapy for prostate cancer Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers Epidemiology of Prostate and Testicular Cancer.The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells.Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Food Habits, Lifestyle Factors, and Risk of Prostate Cancer in Central Argentina: A Case Control Study Involving Self-Motivated Health Behavior Modifications after Diagnosis.Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population.Docetaxel-Loaded Nanoparticles Assembled from β-Cyclodextrin/Calixarene Giant Surfactants: Physicochemical Properties and Cytotoxic Effect in Prostate Cancer and Glioblastoma Cells.18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons.Association between radical prostatectomy and risk of herpes zoster.Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?Assessment of prostate cancer aggressiveness using apparent diffusion coefficient values: impact of patient race and age.TRUS Biopsy Yield in Indian Population: A Retrospective Analysis.Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer.Unusual Case of Laryngeal Squamous Cell Carcinoma with Cervical Metastasis of a Prostatic Adenocarcinoma: A Case Report.Clinical relevance of androgen receptor alterations in prostate cancer.Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management.Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017.Costunolide enhances doxorubicin-induced apoptosis in prostate cancer cells via activated mitogen-activated protein kinases and generation of reactive oxygen species.Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014.Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 inhibits prostate cancer stem cell-induced tumor growth.Trends in prostate cancer incidence between 1996 and 2013 in two Swiss regions by age, grade, and T-stage.Quality of Life Following Prostatectomy as a Function of Surgery Type and Degree of Nerve Sparing.PI3K pathway and Bcl-2 family. Clinicopathological features in prostate cancer.Optimization of temporal sampling for 18F-choline uptake quantification in prostate cancer assessment.Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases.Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer

P2860

Q27004796-935521B2-91A0-419A-AD65-86D7D7DB3BAF Q28075610-9839E7FC-CE72-4390-B99F-0858A22E555C Q30248216-4E6960F8-088F-4A16-A0AB-3E2121A5D190 Q33660177-55BB8BB0-BABB-4B4E-A358-16C4DAE083D2 Q36092572-3D4E1FD4-F425-4828-B512-A555AFD99751 Q37113165-DF130214-0180-4F10-92EE-F2977E350AB7 Q37133056-BC81F745-9BF5-4029-80A3-455B6659FCC0 Q37654357-45BC8EDA-7945-4593-84B1-8B22C9B8D853 Q37665327-1C2C2CF7-6323-421D-979C-BC4FF88A884A Q38769824-C6729EB0-751E-4E96-9F1A-EF83605EF2A8 Q38924757-E79F11EE-2CB6-4611-B2C9-4C75748B712D Q39279262-C9B8EABC-255C-4EFA-9B84-26D3BB8F773D Q39587746-6B1ADDC4-9ED8-4DB9-AA52-D6CCF6183514 Q40349425-BA426B81-EB7B-40ED-BBDE-C4BDC171B68A Q40459312-B6AB63F2-61A4-417E-85A4-F622530EE611 Q41708691-B9EF0655-8557-40DC-AF90-0D9362CF4010 Q41908940-05268BC9-C448-4B43-BA62-414BB9473A78 Q42377108-7950A61A-E9C3-4FDA-8812-4322026A3056 Q42378534-EBE27B80-B485-4C0E-AA01-8D57D70D6543 Q42515447-DF198394-986D-4123-B822-2657827F2781 Q47161875-6F1079F7-D71D-4CAA-84C5-39E90FD77FD8 Q47349096-09EFDA72-F061-4451-89C7-ED8828A261CB Q47368351-CB2D5AE5-29B9-416D-B848-B7BEEBE8C1C7 Q47675170-919BEA64-B885-4677-A703-BFDB413D73F9 Q47880450-D099E66F-18C0-4E67-BEA2-128A538B9860 Q47929908-2C682C69-E169-4648-8D60-F23EF0C0F87D Q48181704-0DB1E5D0-361B-4D9C-BEC0-2E58BC07489A Q49788361-B68F64C8-5F86-4064-864C-58AD7CA16E72 Q50115573-3101932F-5A34-4BE8-BE7A-93DDD7B39F0C Q55395878-2F2FF59A-EA36-42BD-9B4B-79195A4DD536 Q55492100-25139AC7-B837-4776-B3EA-4639BE2E7E6F Q57110000-AB9D30CA-E1E0-43D5-B33B-516BE2E2776A Q58790030-EAD0D26E-8F0B-49C1-BE1E-ECDA6BB31B7A

P2860

Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

http://www.wikidata.org/entity/Q30698121

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Prostate cancer incidence in 4 ...... ends overall and by age group.

@ast

Prostate cancer incidence in 4 ...... ends overall and by age group.

@en

type

label

Prostate cancer incidence in 4 ...... ends overall and by age group.

@ast

Prostate cancer incidence in 4 ...... ends overall and by age group.

@en

prefLabel

Prostate cancer incidence in 4 ...... ends overall and by age group.

@ast

Prostate cancer incidence in 4 ...... ends overall and by age group.

@en

P1433

Q30698121-19633101-A0A9-4177-A9EF-58E2B2E0AF0F

P1476

Q30698121-F3394AD5-C224-498A-8EC6-8B24B17E1CB0

P2093

Q30698121-225D8123-EDD6-4A42-9DF5-14A5532BCC26

Q30698121-22C1DEBA-3E76-44C0-8ADC-E02CD71979EB

Q30698121-87B5FA73-5C3D-493E-90B8-388B4AE335EF

Q30698121-98A49267-0F4A-4D1E-9C40-A8AECBE71094

Q30698121-D1F2EF0D-ABC4-4258-AEF4-EEF9CC1E6272

P2860

Q30698121-07058944-24FF-4687-953D-8C04EDD5CC2C

Q30698121-0E5C3F4E-25CE-46E9-9408-4EB28DD81393

Q30698121-18B92A4F-A559-4BE4-8394-AD6C828D5689

Q30698121-26D03679-512D-4EF4-AC8F-3D93DE0B9F61

Q30698121-37592F81-2013-4AA2-97A8-71CDF966E2BF

Q30698121-3ED922C5-0D9E-4C76-8B71-140B3C9D6DFE

Q30698121-3FD6C2F5-194B-417B-B5D8-4A4CFC5328E6

Q30698121-47BE3D62-C881-4B84-92FB-16C541425473

Q30698121-505FA222-55BF-467B-B650-D9E41CBF962F

Q30698121-5069F460-B465-4B17-BBEB-A01950F0B4C0

P304

Q30698121-5B7974D1-EDE0-4A53-9CF8-7ADD7B14F0FC

P31

Q30698121-99116213-04C8-42B5-9EAA-BC71565F6D6F

P356

Q30698121-37C35E04-2490-460A-A838-D46557FD79A2

P433

Q30698121-D5FF664E-2E51-4DE6-8474-3FDB77D9CCFA

P478

Q30698121-2B7118D3-8F2E-43CA-8BAA-BB382C8A7EBF

P50

Q30698121-15868620-C423-43B9-BBFA-C54E6C3488A4

Q30698121-29F2DFEE-59F9-44ED-A7DC-C17862877F4D

Q30698121-377F47DA-6BBE-48EC-8E90-06CAE1DC112C

Q30698121-89DFEB23-3D9D-46C3-A9C8-32D495E381C2

P577

Q30698121-427BC92F-0939-4EAA-AF64-87461BA73F8A

P698

Q30698121-4DBF8A89-FAB5-4584-916F-ACEBFBE9D974

P932

Q30698121-D19ED702-9E5C-40F3-B84C-58A349B46082

P356

P1433

International Journal of Cancer

P1476

Prostate cancer incidence in 4 ...... rends overall and by age group

@en

P2093

Ahmedin Jemal

http://www.w3.org/2001/XMLSchema#string

David P Check

http://www.w3.org/2001/XMLSchema#string

Jacques Ferlay

http://www.w3.org/2001/XMLSchema#string

Joannie Lortet-Tieulent

http://www.w3.org/2001/XMLSchema#string

Michael B Cook

http://www.w3.org/2001/XMLSchema#string

P2860

Early detection of prostate cancer: AUA Guideline.

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

The role of increasing detection in the rising incidence of prostate cancer.

Prostate cancer in young men: an important clinical entity.

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team.

American Cancer Society guidelines for the early detection of cancer.

Prostate specific antigen best practice statement: 2009 update.

Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States

Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa.

P304

1388-1400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.29894

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Mathieu Laversanne

P577

2015-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26488767

http://www.w3.org/2001/XMLSchema#string

P932

4712103

http://www.w3.org/2001/XMLSchema#string